SCHEMBL7262913

SCHEMBL7262913

CC(C)(C)[Si](C)(C)Oc1ccc(C=O)cc1C1CCCC1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
TSHR P16473 1/20 0.36
PTGDR2 Q9Y5Y4 13/20 0.34
PTGDR Q13258 6/20 0.34
AOX1 Q06278 1/20 0.34
DRD2 P14416 1/20 0.33
ALDH1A3 P47895 1/20 0.33
FDPS P14324 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PTGER2 P43116 1/20 0.32
TRIM24 O15164 1/20 0.31
HPGD P15428 1/20 0.31
ALDH5A1 P51649 1/20 0.31
ABAT P80404 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
TRIM33 Q9UPN9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449762 0.83 PTGDR2 (0.37) PTGDR2PTGDRPTGER2
SCHEMBL7257541 0.83 KDM4E (0.44) ALDH1A1PTGDR2PTGDRHPGDTDP1
SCHEMBL7257530 0.83 KDM4E (0.44) ALDH1A1PTGDR2PTGDRHPGDTDP1
SCHEMBL26132269 0.82 ALDH1A1 (0.36) ALDH1A1TSHRAOX1DRD2ALDH1A3
SCHEMBL7262052 0.81 NR1H4 (0.43) ALDH1A1PTGDR2PTGDRHPGD
SCHEMBL7262044 0.81 NR1H4 (0.43) ALDH1A1PTGDR2PTGDRHPGD
SCHEMBL3925300 0.80 PTGDR2 (0.39) ALDH1A1TSHRPTGDR2PTGDRAOX1
SCHEMBL6449169 0.80 PTGDR2 (0.51) ALDH1A1PTGDR2PTGDRPTGER2HPGD
SCHEMBL6407399 0.79 ALDH1A1 (0.56) ALDH1A1TSHRPTGDR2PTGDRAOX1
SCHEMBL30360260 0.78 ALDH1A1 (0.50) ALDH1A1TSHRAOX1DRD2ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728018-B1 New enzymes and prodrugs for ADEPT WELLCOME FOUND (GB) 2003-08-06 EP disclosed
US-6319702-B1 NUCLEOTIDE SEQUENCS CODING AN ENZYMATIC POLYPEPTIDE AND CELL TARGETING COMPOUND; FOR USE IN TREATMENT OF CANCER GLAXO WELLCOME, INC. 2001-11-20 US disclosed
US-6140100-A CONJUGATE POLYPEPTIDE WHICH IS TISSUE PREFERENTIAL; ANTICARCINOGENIC AGENTS GLAXO WELLCOME INC. (US) 2000-10-31 US disclosed
EP-0728018-A1 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1996-08-28 EP disclosed
WO-1995013095-A2 THERAPY THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-18 WO disclosed